Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Jan;55(1):33–42. doi: 10.1172/JCI107915

Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli.

J Weiss, R C Franson, S Beckerdite, K Schmeidler, P Elsbach
PMCID: PMC301714  PMID: 1088909

Abstract

Recently we reported that rapid killing of Escherichia coli by granulocytes or granulocyte fractions is accompanied by an equally rapid and discrete increase in permeability of the microbial envelope (Beckerdite, Mooney, Weiss, Franson, and Elsbach. 1974. J. Exp. Med. 140: 396-409). Most of this permeability-increasing activity (PI) is found in a crude granule preparation. PI is quantitatively recovered in a 23,000-g supernatant fraction (Sup II) after sulfuric acid extraction of granulocyte homogenates prepared in water. PI is nondialyzable, destroyed by pronase and trypsin, stable at 4degreesC for at least 2 mo, and destroyed by heating at 94degreesC. Anionic substances, such as heparin sulfate and isolated E. coli lipopolysaccharide, bind to and inhibit PI. PI has been purified up to 1,000-fold from homogenate in a yield of 50percent by acid extraction and carboxymethyl-Sephadex chromatography. Such purified fractions have bactericidal activity that equals that of disrupted granulocytes and Sup II, are similarly enriched with respect to granule-associated phospholipase, and protease activities. Whereas E. coli, sensitive to PI, binds or inactivates solubilized PI, a resistant strain of Serratia marcescens does not. Binding of PI to sensitive microorganisms seems to be necessary for expression of its biological activity since both the apparent binding to and the biological effect of PI on E. coli are completely blocked by 10-20 mM Mg2+ or Ca2+. Mg2+ or Ca2+ can reverse the effect on E. coli permeability produced by Sup II or the carboxymethyl-Sephadex fraction but not that produced by granulocyte homogenate. The close association of bactericidal, phospholipase A2, and permeability-increasing activities towards several gram-negative bacterial species suggests that they may be related.

Full text

PDF
33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBERT A. Avidity of terramycin and aureomycin for metallic cations. Nature. 1953 Aug 1;172(4370):201–201. doi: 10.1038/172201a0. [DOI] [PubMed] [Google Scholar]
  2. Beckerdite S., Mooney C., Weiss J., Franson R., Elsbach P. Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes. J Exp Med. 1974 Aug 1;140(2):396–409. doi: 10.1084/jem.140.2.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. COHN Z. A., HIRSCH J. G. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J Exp Med. 1960 Dec 1;112:983–1004. doi: 10.1084/jem.112.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COHN Z. A. The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages. J Exp Med. 1963 Jan 1;117:27–42. doi: 10.1084/jem.117.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cavard D., Rampini C., Barbu E., Polonovski J. Activité phospholipasique et autres modifications du métabolisme des phospholipides consécutives a l'action des colicines sur E. coli. Bull Soc Chim Biol (Paris) 1968 Dec;50(9):1455–1471. [PubMed] [Google Scholar]
  6. Chen C. C., Feingold D. S. Locus of divalent cation inhibition of the bactericidal action of polymyxin B. Antimicrob Agents Chemother. 1972 Nov;2(5):331–335. doi: 10.1128/aac.2.5.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crawford L. M. Calcium inhibition of antibacterial activity of kanamycin. Am J Vet Res. 1972 Aug;33(8):1685–1688. [PubMed] [Google Scholar]
  8. Devynck M. A., Boquet P. L., Fromageot P. On the mode of action of levallorphan on Escherichia coli: effects on cellular magnesium. Mol Pharmacol. 1971 Nov;7(6):605–610. [PubMed] [Google Scholar]
  9. ELSBACH P., SCHWARTZ I. L. Studies on the sodium and potassium transport in rabbit polymorphonuclear leukocytes. J Gen Physiol. 1959 May 20;42(5):883–898. doi: 10.1085/jgp.42.5.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Elsbach P., Beckerdite S., Pettis P., Franson R. Persistence of regulation of macromolecular synthesis by Escherichia coli during killing by disrupted rabbit granulocytes. Infect Immun. 1974 Apr;9(4):663–668. doi: 10.1128/iai.9.4.663-668.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elsbach P., Goldman J., Patriarca P. Phospholipid metabolism by phagocytic cells. VI. Observations on the fate of phospholipids of granulocytes and ingested Escherichia coli during phagocytosis. Biochim Biophys Acta. 1972 Sep 7;280(1):33–44. [PubMed] [Google Scholar]
  12. Elsbach P. On the interaction between phagocytes and micro-organisms. N Engl J Med. 1973 Oct 18;289(16):846–852. doi: 10.1056/NEJM197310182891610. [DOI] [PubMed] [Google Scholar]
  13. Elsbach P., Pettis P., Beckerdite S., Franson R. Effects of phagocytosis by rabbit granulocytes on macromolecular synthesis and degradation in different species of bacteria. J Bacteriol. 1973 Aug;115(2):490–497. doi: 10.1128/jb.115.2.490-497.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Feingold D. S., Goldman J. N., Kuritz H. M. Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction. J Bacteriol. 1968 Dec;96(6):2118–2126. doi: 10.1128/jb.96.6.2118-2126.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Franson R., Patriarca P., Elsbach P. Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules. J Lipid Res. 1974 Jul;15(4):380–388. [PubMed] [Google Scholar]
  16. HIGASHI Y., KURIMURA T., KUWAHARA O., OZAKI M., AMANO T. STUDIES ON THE ROLE OF PLAKIN. X. EFFECT ON MEMBRANE PHOSPHOLIPIDS. Biken J. 1963 Jul;6:111–126. [PubMed] [Google Scholar]
  17. HIRSCH J. G. Bactericidal action of histone. J Exp Med. 1958 Dec 1;108(6):925–944. doi: 10.1084/jem.108.6.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HIRSCH J. G. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Exp Med. 1956 May 1;103(5):589–611. doi: 10.1084/jem.103.5.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. HURWITZ J., FURTH J. J., MALAMY M., ALEXANDER M. The role of deoxyribonucleic acid in ribonucleic acid synthesis. III. The inhibition of the enzymatic synthesis of ribonucleic acid and deoxyribonucleic acid by actinomycin D and proflavin. Proc Natl Acad Sci U S A. 1962 Jul 15;48:1222–1230. doi: 10.1073/pnas.48.7.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. HsuChen C. C., Feingold D. S. The mechanism of polymyxin B action and selectivity toward biologic membranes. Biochemistry. 1973 May 22;12(11):2105–2111. doi: 10.1021/bi00735a014. [DOI] [PubMed] [Google Scholar]
  21. LEIVE L. ACTINOMYCIN SENSITIVITY IN ESCHERICHIA COLI PRODUCED BY EDTA. Biochem Biophys Res Commun. 1965 Jan 4;18:13–17. doi: 10.1016/0006-291x(65)90874-0. [DOI] [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Leive L., Kollin V. Controlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes. Biochem Biophys Res Commun. 1967 Jul 21;28(2):229–236. doi: 10.1016/0006-291x(67)90434-2. [DOI] [PubMed] [Google Scholar]
  24. Leive L. Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. J Biol Chem. 1968 May 10;243(9):2373–2380. [PubMed] [Google Scholar]
  25. Muschel L. H., Jackson J. E. Reversal of the bactericidal reaction of serum by magnesium ion. J Bacteriol. 1966 Apr;91(4):1399–1402. doi: 10.1128/jb.91.4.1399-1402.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reynolds B. L., Pruul H. Sensitization of complement-resistant smooth gram-negative bacterial strains. Infect Immun. 1971 Mar;3(3):365–372. doi: 10.1128/iai.3.3.365-372.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SCHULTZ J., SHAY H., GRUENSTEIN M. The chemistry of experimental chloroma I. Porphyrins and peroxidases. Cancer Res. 1954 Mar;14(3):157–162. [PubMed] [Google Scholar]
  28. SHUGAR D. The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme. Biochim Biophys Acta. 1952 Mar;8(3):302–309. doi: 10.1016/0006-3002(52)90045-0. [DOI] [PubMed] [Google Scholar]
  29. Schnaitman C. A. Effect of ethylenediaminetetraacetic acid, Triton X-100, and lysozyme on the morphology and chemical composition of isolate cell walls of Escherichia coli. J Bacteriol. 1971 Oct;108(1):553–563. doi: 10.1128/jb.108.1.553-563.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. WEINBERG E. D. The mutual effects of antimicrobial compounds and metallic cations. Bacteriol Rev. 1957 Mar;21(1):46–68. doi: 10.1128/br.21.1.46-68.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wilson L. A., Spitznagel J. K. Characteristics of complement-dependent release of phospholipid from Escherichia coli. Infect Immun. 1971 Jul;4(1):23–28. doi: 10.1128/iai.4.1.23-28.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. ZEYA H. I., SPITZNAGEL J. K. ANTIBACTERIAL AND ENZYMIC BASIC PROTEINS FROM LEUKOCYTE LYSOSOMES: SEPARATION AND IDENTIFICATION. Science. 1963 Nov 22;142(3595):1085–1087. doi: 10.1126/science.142.3595.1085. [DOI] [PubMed] [Google Scholar]
  33. Zeya H. I., Spitznagel J. K. Cationic proteins of polymorphonuclear leukocyte lysosomes. II. Composition, properties, and mechanism of antibacterial action. J Bacteriol. 1966 Feb;91(2):755–762. doi: 10.1128/jb.91.2.755-762.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zimelis V. M., Jackson G. G. Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis. 1973 Jun;127(6):663–669. doi: 10.1093/infdis/127.6.663. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES